Legend Biotech (LEGN) Equity Ratio: 2019-2025
Historic Equity Ratio for Legend Biotech (LEGN) over the last 5 years, with Sep 2025 value amounting to 0.59.
- Legend Biotech's Equity Ratio fell 8.18% to 0.59 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.59, marking a year-over-year decrease of 8.18%. This contributed to the annual value of 0.62 for FY2024, which is 7.96% down from last year.
- Legend Biotech's Equity Ratio amounted to 0.59 in Q3 2025, which was down 3.66% from 0.61 recorded in Q2 2025.
- Over the past 5 years, Legend Biotech's Equity Ratio peaked at 0.73 during Q2 2023, and registered a low of -18,000.00 during Q3 2022.
- Its 3-year average for Equity Ratio is 0.64, with a median of 0.64 in 2024.
- Over the last 5 years, Legend Biotech's Equity Ratio had its largest YoY gain of 111.53% in 2022, and its largest YoY loss of 6,485,259.34% in 2022.
- Legend Biotech's Equity Ratio (Quarterly) stood at 0.68 in 2021, then decreased by 18.27% to 0.56 in 2022, then grew by 21.05% to 0.68 in 2023, then declined by 7.96% to 0.62 in 2024, then dropped by 8.18% to 0.59 in 2025.
- Its Equity Ratio was 0.59 in Q3 2025, compared to 0.61 in Q2 2025 and 0.63 in Q1 2025.